List of insiders holdings for Anika Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | SHERWOOD CHARLES H CEO and Director | 2018-03-22 16:30:14 | 789,547 0 | 789,547 | Form 13G |
2 | Blanchard Cheryl R President, CEO, Director | 2025-03-18 17:15:49 | 392,545 11,742 | 404,287 | Form 4 |
3 | KNIGHT WILLIAM J CFO | 2004-09-29 16:58:44 | 155,000 0 | 155,000 | Form 4 |
4 | Colleran David EVP, General Counsel, Corp Sec | 2025-03-18 17:16:12 | 102,685 0 | 102,685 | Form 4 |
5 | Chen Elizabeth Sr. VP Mktg. & Bus. Dev. | 2004-10-06 12:54:55 | 100,000 0 | 100,000 | Form 4 |
6 | Litman Peter VP, Business Development | 2005-10-04 16:01:51 | 100,000 0 | 100,000 | Form 4 |
7 | Levitz Michael L EVP, CFO, Treasurer | 2024-03-19 17:23:42 | 73,011 0 | 73,011 | Form 4 |
8 | DAVIDSON EUGENE A Director | 2011-01-20 16:06:02 | 71,763 0 | 71,763 | Form 4 |
9 | Cheung Sylvia Chief Financial Officer | 2020-02-27 18:49:20 | 60,981 0 | 60,981 | Form 4 |
10 | Nunes Anne SVP, Chief Operations Officer | 2025-03-18 17:16:55 | 53,340 0 | 53,340 | Form 4 |
11 | Larsen Glenn R. Director | 2025-06-24 17:13:04 | 50,258 0 | 50,258 | Form 4 |
12 | VOGT SUSAN L N Director | 2025-06-24 17:14:37 | 50,213 0 | 50,213 | Form 4 |
13 | Garrison Constance H VP Reg.,Clinical & Qlty. Sys. | 2006-11-09 16:11:42 | 50,000 0 | 50,000 | Form 4 |
14 | HENNEMAN JOHN B III Director | 2025-06-24 17:06:28 | 49,871 0 | 49,871 | Form 4 |
15 | Richard Stephen Director | 2025-06-24 17:13:40 | 47,871 0 | 47,871 | Form 4 |
16 | McLeod Ian VP, CAO and Treasurer | 2025-04-11 16:46:31 | 46,124 0 | 46,124 | Form 3 |
17 | CONLEY SHERYL L Director | 2025-06-24 17:05:30 | 42,568 0 | 42,568 | Form 4 |
18 | Fischetti Gary P Director | 2025-06-24 17:06:05 | 41,613 0 | 41,613 | Form 4 |
19 | SHEETS JOHN W JR Chief Scientific Officer | 2013-10-04 18:23:03 | 40,000 0 | 40,000 | Form 4 |
20 | Mascioli Stephen R. Chief Medical Officer | 2016-04-06 16:26:04 | 40,000 0 | 40,000 | Form 4 |
21 | WHEELER STEVE E Director | 2018-01-26 16:12:14 | 37,707 0 | 37,707 | Form 4 |
22 | Griffin Stephen D. EVP, CFO & COO | 2025-06-05 17:01:13 | 35,551 0 | 35,551 | Form 4 |
23 | Thompson Jeffery S Director | 2023-06-16 16:17:11 | 31,575 0 | 31,575 | Form 4 |
24 | Finnerty Thomas EVP, Human Resources | 2022-03-11 17:36:20 | 29,695 0 | 29,695 | Form 4 |
25 | QUINLAN KEVIN W Chief Financial Officer | 2013-04-02 11:05:31 | 27,112 0 | 27,112 | Form 4 |
26 | Mrachek William Vice President, Human Resource | 2011-01-20 16:07:18 | 25,000 0 | 25,000 | Form 4 |
27 | Jellison William R Director | 2025-06-24 17:12:27 | 20,403 2,700 | 23,103 | Form 4 |
28 | Capper Joseph H Director | 2025-06-24 17:04:54 | 20,403 0 | 20,403 | Form 4 |
29 | Darling Joseph G President and CEO; Director | 2019-07-30 16:05:38 | 20,289 0 | 20,289 | Form 4 |
30 | BARNETT CAROL A Chief Commercial Officer | 2014-01-29 18:51:14 | 19,900 0 | 19,900 | Form 4 |
31 | Bower Joseph L. Director | 2020-02-27 18:50:16 | 17,117 0 | 17,117 | Form 4 |
32 | Alexander Dana M. Chief Operations Officer | 2017-01-31 16:06:34 | 16,875 0 | 16,875 | Form 4 |
33 | Moran John C Director | 2015-08-11 16:06:00 | 14,803 0 | 14,803 | Form 4 |
34 | Toth Carol A VP, Research and Development | 2006-01-30 15:33:49 | 13,000 0 | 13,000 | Form 4 |
35 | Hague Richard Chief Commercial Officer | 2019-02-28 16:34:13 | 12,777 0 | 12,777 | Form 4 |
36 | LAND RAYMOND J Director | 2021-06-21 16:16:24 | 12,125 0 | 12,125 | Form 4 |
37 | Ahn Edward S. Chief Tech & Strategy Officer | 2019-02-28 16:30:23 | 10,125 0 | 10,125 | Form 4 |
38 | SADOW HARVEY S Director | 2006-09-12 15:41:06 | 10,000 0 | 10,000 | Form 4 |
39 | Loerop James EVP Business Development | 2021-07-12 16:15:29 | 8,592 0 | 8,592 | Form 4 |
40 | ONeill James E Chief Accounting Officer | 2005-02-14 16:27:11 | 6,000 0 | 6,000 | Form 4 |
41 | LUPPINO FRANCESCO J Chief Operating Officer | 2015-02-05 17:07:39 | 3,100 0 | 3,100 | Form 4 |
42 | MCKAY SAMUEL F Director | 2006-01-26 09:31:02 | 1,275 0 | 1,275 | Form 4 |
43 | Fidia Farmaceutici S.p.A. P&R S.p.A. Fiore Holding S.r.l. 10% Owner | 2013-11-22 11:43:59 | 0 0 | 0 | Form 13G |